• ¬³¬à¬Ö¬Õ¬Ú¬ß¬Ö¬ß¬Ú¬Ö ¬Ü¬à¬Þ¬á¬Ñ¬ß¬Ú¬Û
  • ¬ª¬ã¬ã¬Ý¬Ö¬Õ¬à¬Ó¬Ñ¬ß¬Ú¬ñ ¬Ú ¬Ú¬ã¬ã¬Ý¬Ö¬Õ¬à¬Ó¬Ñ¬ß¬Ú¬ñ
  • ¬±¬â¬à¬Õ¬å¬Ü¬è¬Ú¬ñ
  • ¬²¬Ñ¬Ù¬â¬Ñ¬Ò¬à¬ä¬Ü¬Ñ ¬ã¬í¬â¬î¬ñ
  • ¬ª¬ã¬ã¬Ý¬Ö¬Õ¬à¬Ó¬Ñ¬ß¬Ú¬ñ ¬Ú ¬Ú¬ã¬ã¬Ý¬Ö¬Õ¬à¬Ó¬Ñ¬ß¬Ú¬ñ
  • PR
  • ¬°¬Ò¬Ù¬à¬â ¬Ü¬à¬Þ¬á¬Ñ¬ß¬Ú¬Ú
  • ¬Ú¬ã¬ä¬à¬â¬Ú¬ñ
  • ¬ª¬ã¬á¬à¬Ý¬ß¬Ú¬ä¬Ö¬Ý¬î¬ß¬à¬Ö ¬Ó¬Ó¬Ö¬Õ¬Ö¬ß¬Ú¬Ö
  • ¬ª¬ß¬Ó¬Ö¬ã¬ä¬Ú¬è¬Ú¬à¬ß¬ß¬Ñ¬ñ ¬à¬â¬Ô¬Ñ¬ß¬Ú¬Ù¬Ñ¬è¬Ú¬ñ
  • ExoSCRT Exosome
  • Regenerative Therapeutics
  • Immuno Oncology
  • ASCE+ Skin
  • ASCE+ Hair
  • Exomage
  • Celltweet
  • Lapuroon
  • Celosome
  • ExoBRID-E
  • Vexosome
  • Rose Exosome
  • ¬á¬Ñ¬ä¬Ö¬ß¬ä
  • ¬¢¬å¬Þ¬Ñ¬Ô¬Ñ
  • ¬±¬â¬Ñ¬Ó¬Ú¬ä¬Ö¬Ý¬î¬ã¬ä¬Ó¬Ö¬ß¬ß¬í¬Ö ¬Ù¬Ñ¬Õ¬Ñ¬é¬Ú
  • ¬¬¬à¬â¬Ö¬ñ PR
  • ¬©¬Ñ¬â¬å¬Ò¬Ö¬Ø¬ß¬í¬Û PR
  • ¬£¬ß¬å¬ä¬â¬Ö¬ß¬ß¬Ú¬Û ¬¯¬à¬Ó¬à¬ã¬ä¬Ú
  • ¬Õ¬à¬Þ¬à¬Û
  • 1:1 ¬Ù¬Ñ¬á¬â¬à¬ã
  • ¬Á¬©¬½¬¬
    KOR
    ENG
    RUS

¬³¬à¬Ö¬Õ¬Ú¬ß¬Ö¬ß¬Ú¬Ö ¬Ü¬à¬Þ¬á¬Ñ¬ß¬Ú¬Û

  • ¬°¬Ò¬Ù¬à¬â ¬Ü¬à¬Þ¬á¬Ñ¬ß¬Ú¬Ú
  • ¬Ú¬ã¬ä¬à¬â¬Ú¬ñ
  • ¬ª¬ã¬á¬à¬Ý¬ß¬Ú¬ä¬Ö¬Ý¬î¬ß¬à¬Ö ¬Ó¬Ó¬Ö¬Õ¬Ö¬ß¬Ú¬Ö
  • ¬ª¬ß¬Ó¬Ö¬ã¬ä¬Ú¬è¬Ú¬à¬ß¬ß¬Ñ¬ñ ¬à¬â¬Ô¬Ñ¬ß¬Ú¬Ù¬Ñ¬è¬Ú¬ñ

R & D

  • ExoSCRT Exosome
  • Regenerative Therapeutics
  • Immuno Oncology

¬ä¬à¬Ó¬Ñ¬â

  • ASCE+ Skin
  • ASCE+ Hair
  • Exomage
  • Celltweet
  • Lapuroon
  • Celosome

¬²¬Ñ¬Ù¬â¬Ñ¬Ò¬à¬ä¬Ü¬Ñ ¬ã¬í¬â¬î¬ñ

  • ExoBRID-E
  • Vexosome
  • Rose Exosome

¬ª¬ã¬ã¬Ý¬Ö¬Õ¬à¬Ó¬Ñ¬ß¬Ú¬Ö ¬á¬â¬à¬Ú¬Ù¬Ó¬à¬Õ¬Ú¬ä¬Ö¬Ý¬î¬ß¬à¬ã¬ä¬Ú

  • ¬á¬Ñ¬ä¬Ö¬ß¬ä
  • ¬¢¬å¬Þ¬Ñ¬Ô¬Ñ
  • ¬©¬Ñ¬Õ¬Ñ¬é¬Ñ ¬á¬â¬Ñ¬Ó¬Ú¬ä¬Ö¬Ý¬î¬ã¬ä¬Ó¬Ñ

PR

  • ¬¬¬à¬â¬Ö¬ñ PR
  • ¬©¬Ñ¬â¬å¬Ò¬Ö¬Ø¬ß¬í¬Û PR
  • ¬£¬ß¬å¬ä¬â¬Ö¬ß¬ß¬Ú¬Û ¬¯¬à¬Ó¬à¬ã¬ä¬Ú
  • KOR
  • ENG
  • RUS

¬³¬à¬Ö¬Õ¬Ú¬ß¬Ö¬ß¬Ú¬Ö ¬Ü¬à¬Þ¬á¬Ñ¬ß¬Ú¬Û

  • ¬°¬Ò¬Ù¬à¬â ¬Ü¬à¬Þ¬á¬Ñ¬ß¬Ú¬Ú
  • ¬Ú¬ã¬ä¬à¬â¬Ú¬ñ
  • ¬ª¬ã¬á¬à¬Ý¬ß¬Ú¬ä¬Ö¬Ý¬î¬ß¬à¬Ö ¬Ó¬Ó¬Ö¬Õ¬Ö¬ß¬Ú¬Ö
  • ¬ª¬ß¬Ó¬Ö¬ã¬ä¬Ú¬è¬Ú¬à¬ß¬ß¬Ñ¬ñ ¬à¬â¬Ô¬Ñ¬ß¬Ú¬Ù¬Ñ¬è¬Ú¬ñ

R & D

  • ExoSCRT Exosome
  • Regenerative Therapeutics
  • Immuno Oncology

¬ä¬à¬Ó¬Ñ¬â

  • ASCE+ Skin
  • ASCE+ Hair
  • Exomage
  • Celltweet
  • Lapuroon
  • Celosome

¬²¬Ñ¬Ù¬â¬Ñ¬Ò¬à¬ä¬Ü¬Ñ ¬ã¬í¬â¬î¬ñ

  • ExoBRID-E
  • Vexosome
  • Rose Exosome

¬ª¬ã¬ã¬Ý¬Ö¬Õ¬à¬Ó¬Ñ¬ß¬Ú¬Ö ¬á¬â¬à¬Ú¬Ù¬Ó¬à¬Õ¬Ú¬ä¬Ö¬Ý¬î¬ß¬à¬ã¬ä¬Ú

  • ¬á¬Ñ¬ä¬Ö¬ß¬ä
  • ¬¢¬å¬Þ¬Ñ¬Ô¬Ñ
  • ¬©¬Ñ¬Õ¬Ñ¬é¬Ñ ¬á¬â¬Ñ¬Ó¬Ú¬ä¬Ö¬Ý¬î¬ã¬ä¬Ó¬Ñ

PR

  • ¬¬¬à¬â¬Ö¬ñ PR
  • ¬Ù¬Ñ ¬â¬å¬Ò¬Ö¬Ø¬à¬Þ PR
  • ¬¯¬à¬Ó¬à¬ã¬ä¬Ú ¬Ü¬à¬Þ¬á¬Ñ¬ß¬Ú¬Ú
¬´¬à¬Ó¬Ñ¬â

¬´¬à¬Ó¬Ñ¬â

scroll

  • Product

¬´¬à¬Ó¬Ñ¬â

¬¿¬ã¬ä¬Ö¬ä¬Ú¬Ü¬Ñ, ¬ã¬à¬Ù¬Õ¬Ñ¬ß¬ß¬Ñ¬ñ ¬á¬à ¬ä¬Ö¬ç¬ß¬à¬Ý¬à¬Ô¬Ú¬Ú ExoSCRT

  • ¬ã¬Þ¬à¬ä¬â¬Ö¬ä¬î ¬Ò¬à¬Ý¬î¬ê¬Ö
  • ¬ã¬Þ¬à¬ä¬â¬Ö¬ä¬î ¬Ò¬à¬Ý¬î¬ê¬Ö
  • ¬ã¬Þ¬à¬ä¬â¬Ö¬ä¬î ¬Ò¬à¬Ý¬î¬ê¬Ö
  • ¬ã¬Þ¬à¬ä¬â¬Ö¬ä¬î ¬Ò¬à¬Ý¬î¬ê¬Ö
  • ¬ã¬Þ¬à¬ä¬â¬Ö¬ä¬î ¬Ò¬à¬Ý¬î¬ê¬Ö
  • ¬ã¬Þ¬à¬ä¬â¬Ö¬ä¬î ¬Ò¬à¬Ý¬î¬ê¬Ö
  • ¬ã¬Þ¬à¬ä¬â¬Ö¬ä¬î ¬Ò¬à¬Ý¬î¬ê¬Ö
  • ¬ã¬Þ¬à¬ä¬â¬Ö¬ä¬î ¬Ò¬à¬Ý¬î¬ê¬Ö
  • ¬ã¬Þ¬à¬ä¬â¬Ö¬ä¬î ¬Ò¬à¬Ý¬î¬ê¬Ö
  • ¬ã¬Þ¬à¬ä¬â¬Ö¬ä¬î ¬Ò¬à¬Ý¬î¬ê¬Ö
  • ¬ã¬Þ¬à¬ä¬â¬Ö¬ä¬î ¬Ò¬à¬Ý¬î¬ê¬Ö
  • ¬ã¬Þ¬à¬ä¬â¬Ö¬ä¬î ¬Ò¬à¬Ý¬î¬ê¬Ö

¬Ü¬à¬â¬á¬à¬â¬Ñ¬è¬Ú¬ñ Exocobio / ¬á¬â¬Ö¬Õ¬ã¬ä¬Ñ¬Ó¬Ú¬ä¬Ö¬Ý¬î : ¬¹¬à ¬¢¬×¬ß ¬³¬å¬ß¬Ô
19, Gasan Digital 1-ro, Geumcheon-gu, ¬³¬Ö¬å¬Ý, 18-¬Û ¬¥¬Ñ¬Ö¬â¬ð¬ß¬Ô ¬´¬Ö¬ç¬ß¬à ¬´¬Ñ¬å¬ß
¬Ü¬à¬ß¬ä¬Ñ¬Ü¬ä : 02.2038.3915 / ¬¿¬­. ¬¡¬¥¬²¬¦¬³ : info@exocobio.com

¬³¬à¬Ö¬Õ¬Ú¬ß¬Ö¬ß¬Ú¬Ö ¬Ü¬à¬Þ¬á¬Ñ¬ß¬Ú¬Û
  • ¬ª¬ã¬ã¬Ý¬Ö¬Õ¬à¬Ó¬Ñ¬ß¬Ú¬ñ ¬Ú ¬Ú¬ã¬ã¬Ý¬Ö¬Õ¬à¬Ó¬Ñ¬ß¬Ú¬ñ
  • ¬±¬â¬à¬Õ¬å¬Ü¬è¬Ú¬ñ
  • ¬²¬Ñ¬Ù¬â¬Ñ¬Ò¬à¬ä¬Ü¬Ñ ¬ã¬í¬â¬î¬ñ
  • ¬ª¬ã¬ã¬Ý¬Ö¬Õ¬à¬Ó¬Ñ¬ß¬Ú¬ñ ¬Ú ¬Ú¬ã¬ã¬Ý¬Ö¬Õ¬à¬Ó¬Ñ¬ß¬Ú¬ñ
¬ª¬ã¬ã¬Ý¬Ö¬Õ¬à¬Ó¬Ñ¬ß¬Ú¬ñ ¬Ú ¬Ú¬ã¬ã¬Ý¬Ö¬Õ¬à¬Ó¬Ñ¬ß¬Ú¬ñ
  • ExoSCRT Exosome
  • Regenerative Therapeutics
  • Immuno Oncology
¬±¬â¬à¬Õ¬å¬Ü¬è¬Ú¬ñ
  • ASCE+ Skin
  • ASCE+ Hair
  • Exomage
  • Celltweet
  • Lapuroon
  • Celosome
COPYRIGHT(C)2020 EXOCOBIO.ALL RIGHT RESERVED